Table 1 Baseline patient characteristics
|  | Usual Care (n = 29) | Intervention (n = 30) | p-value |
|---|---|---|---|
Age (years) (median, IQR) | 83 (79–86) | 83 (78–88) | 0.933 |
Weight (kg) (median, IQR) | 72 (63–81) | 71 (60–81) | 0.814 |
Sex (male/female) | 13/16 | 13/17 | 1.000 |
Number of preadmission drugs (median, IQR) | 7.0 (6.0–11.0) | 9.5 (5.8–13) | 0.199 |
Patients with at least 1 RASP PIM (%) | 100% | 96.7% | 1.000 |
Patients with > 5 drugs (%) | 82.8% | 90.0% | 0.472 |
Patients with > 10 drugs (%) | 37.9% | 50% | 0.435 |
Number of preadmission RASP PIMs (median, IQR) | 3.0 (2.0–5.0) | 3.5 (2.0–5.0) | 0.437 |
Age-adjusted Charlson Comorbidity Index (median, IQR) | 6 (5–8) | 7 (5–8) | 0.145 |
Serum creatinine (mg/dl) (median, IQR) | 0.97 (0.78–1.41) | 1.17 (0.90–1.49) | 0.285 |
eGFR CKD-EPI (ml/min/1,73m2) (median, IQR) | 63 (43–80) | 50 (38–68) | 0.148 |
CrCl CG (ml/min) (median, IQR) | 52 (42–64) | 43 (32–54) | 0.159 |